Janssen Search
Search results
We Need a 'Surge' in RSV Awareness
We Need a 'Surge' in RSV Awareness COVID-19 has been an ever-present part of our lives since 2020 and has altered nearly all the ways in which we interact with the world and with one another. The pandemic has also led to an overall increase in ...
Cracking the Code: How New Clues in Our Blood Could Sharpen Our Understanding of Diseases and Impact How We Treat Them
Cracking the Code: How New Clues in Our Blood Could Sharpen Our Understanding of Diseases and Impact How We Treat Them Nearly 20 years ago, scientific leaders in the United Kingdom began an ambitious endeavor: to create UK Biobank, a uniquely powerful ...
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
Jan 18, 2023 The Netherlands Independent, scheduled review of Phase 3 Mosaico study finds investigational vaccine regimen lacks efficacy in preventing HIV No vaccine-related safety issues identified LEIDEN, THE NETHERLANDS, (January 18, 2023) – The ...
Increasing Sustainable Access to Medicines
Increasing Sustainable Access to Medicines Janssen, as part of its commitment to Global Public Health, cultivates and helps implement innovative pricing and results-based financing models that improve access to our medicines for patients in resource ...
Janssen Oncology Strengthens Disease Interception Focus with TARIS’ Unique Delivery System
Janssen Oncology Strengthens Disease Interception Focus with TARIS' Unique Delivery System Aug 14, 2020 A small pretzel-shaped device designed as a novel approach for the treatment of bladder cancer attracted Janssen Oncology to TARIS Biomedical in ...
Profiles in Scientific Courage: The First Cancer Cures
Profiles in Scientific Courage: The First Cancer Cures It Takes More Than Just Science During this pandemic year, our sense of urgency in the biomedical research community has been sharpened and tested. In oncology research, I believe that this is a time ...
Our Commitment to Rheumatology
About Rheumatoid Arthritis Rheumatoid arthritis (RA) is a chronic, symmetric, inflammatory disease involving the synovial joints, where bone and cartilage erosion lead to irreversible joint damage. 1 Despite advancements in treatments, 20 to 30 percent of ...
Janssen Receives Positive CHMP Opinion for Novel Bispecific Antibody TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma (RRMM)
Jul 22, 2022 Belgium Teclistamab is the first T-cell redirecting bispecific antibody to receive a positive CHMP opinion for adults with RRMM and highlights Janssen’s commitment to innovation in multiple myeloma The opinion is based on the MajesTEC-1 study ...
Victories Over Cancer
Article Block Text: Our Cancer Scientists Give Their "Aha!" Moments Article Type: Oncology Research and Innovation This article, written by Ginny Graves, first appeared on jnj.com. One of the biggest health battles the world’s scientists are ...
Dual Perspectives on Digital Twins in Interception Science
Dual Perspectives on Digital Twins in Interception Science In the 1800s, there were several ways to photograph a single image. As image capture was refined, people noticed that successive still photos – or data points – stacked one after another at 10 ...